Physician profile
Azmi Draw
NPI 1801878806
$59,651.26
in general payments reported to CMS, 2019-2025
42 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $1,055 · 2021: $914 · 2022: $3,034 · 2023: $8,991 · 2024: $14K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Food and Beverage: $8,593 · Education: $6,704 · Honoraria: $6,000 · Travel and Lodging: $1,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,720.00 |
| Food and Beverage | $8,592.59 |
| Education | $6,703.61 |
| Honoraria | $6,000.00 |
| Travel and Lodging | $1,877.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $35,275.70 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Intuitive Surgical, INC. | $8,756.42 | 2022-2023 | Da Vinci Surgical System, Ion |
| Verona Pharma, INC. | $6,982.97 | 2025 | Ohtuvayre |
| Glaxosmithkline, LLC. | $1,768.25 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,226.45 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Insmed, INC. | $938.77 | 2019-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $518.06 | 2020-2025 | Wakix |
| Genzyme Corporation | $515.33 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $497.22 | 2023-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $435.33 | 2020-2025 | Glassia |
| Jazz Pharmaceuticals INC. | $316.30 | 2020-2023 | Xywav |
| Amgen INC. | $301.62 | 2023-2025 | Tezspire |
| Mylan Specialty L.P. | $297.50 | 2019-2023 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $284.37 | 2021-2025 | Uptravi, Opsumit |
| Philips North America LLC | $167.70 | 2019-2024 | (Ak6) Vest Therapy |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $158.82 | 2020-2025 | Zemaira |
| Sunovion Pharmaceuticals INC. | $156.16 | 2019-2020 | |
| Pulmonx Corporation | $144.30 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $105.64 | 2021-2025 | Acthar |
| Sanofi-Aventis U.S. LLC | $89.99 | 2025 | |
| Viatris Specialty LLC | $79.20 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $67.01 | 2023 | Quviviq |
| Mayne Pharma Commercial LLC | $64.12 | 2022 | |
| Axsome Therapeutics, INC. | $53.13 | 2023-2024 | Sunosi |
| Grifols USA, LLC | $52.91 | 2019-2024 | Prolastin-C Liquid |
| Baxter Healthcare | $52.73 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Inogen, INC. | $38.58 | 2022-2023 | Inogen At Home Stationary Concentrator |
| Opko Pharmaceuticals, LLC | $36.34 | 2019 | |
| Vanda Pharmaceuticals INC. | $32.47 | 2022 | |
| Covidien Lp | $31.11 | 2019 | |
| Siemens Medical Solutions USA, INC. | $26.45 | 2024 | Cios Spin |
| Electromed, INC. | $21.35 | 2025 | Smartvest |
| Inspire Medical Systems, INC. | $19.38 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $19.04 | 2023 | Belsomra |
| Itamar Medical INC | $17.71 | 2023 | Watchpatone |
| United Therapeutics Corporation | $17.37 | 2025 | Tyvaso |
| Alexion Pharmaceuticals, INC. | $15.54 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.87 | 2023 | Nuzyra |
| Circassia INC. | $14.40 | 2019 | |
| Resmed Corp | $13.92 | 2021 | |
| Liquidia Technologies, INC. | $13.86 | 2025 | Yutrepia |
| 3b Medical, INC. | $12.87 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azmi Draw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.